Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Best Pharma Stocks To Buy + Sector Update By Emkay



Emkay has conducted a detailed study of the Q2CY15 DMF filings by top pharma companies and identified the stocks to buy and hold




Q2 CY15 DMF filings reveal Indian companies have filed for 36% of total filings in Q2 CY15, much lower than the 45% aggregate in 2014 and 47% in 2013. Cumulatively Indian companies filed for 45 molecules in Q2 CY15 compared to 96 in Q1 CY15

Cipla and Alembic file DMF on generics with low competition products –Ambrisentan and Azilsartan respectively. Cipla also filed Albendazole which is off patent but has no generic. Aurobindo, the only Indian filer for injectable for the quarter

Click here to download Emkay’s Pharma sector update
investments, Large Cap, Mid Cap, Portfolio, Top Picks    ,

4 Comments
  1. amit's Gravatar amit
    July 15, 2015 at 7:41 pm | Permalink

    DOLLY KHANNA and ANIL KUMAR GOEL make a big bang entry In RSWM.. Check latest June 2015 shareholding pattern..

    Reply
    • n samraj's Gravatar n samraj
      July 16, 2015 at 2:57 pm | Permalink

      she will also enter kpr mill, sutlej textiles, trident industries

      Reply
  2. amit's Gravatar amit
    July 15, 2015 at 7:52 pm | Permalink

    I think they were drunk while making this report. They said buy and target is negative hell. Company is paying them for writing shit

    Reply
    • mayur's Gravatar mayur
      July 16, 2015 at 5:00 pm | Permalink

      haha..yes noticed same thing…retail investors also paying for negative targets…Bullshit

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 495 other subscribers

RSS Stocks Talk Forum

  • Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide
    Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide. Singhania's Abakkus Fund holds 6.78% worth ₹137 Cr. Kela's Cohesion MK Fund holds 4.07% worth ₹82 Cr. M-Cap is ₹2100 Cr. Promoters hold 37%. Co is dominant in branded Home Textile with a 'fibre to shelf' model
  • Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
    Suraj Estate Developers has a robust project lineup & launch pipeline, leadership position in redevelopment projects, strong cost advantage, proven track record, huge addressable market and healthy Balance Sheet with predictable cash flows. TP ₹992 (+73%) Download research report... Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
  • DCX Systems has the ability to become a key player in EMS space. TP ₹466 (+54%)
    DCX Systems has the ability to become a key player in EMS space with huge potential in railway & defence. It has ability to deliver high value complicated & critical products for leading defense players L&T & Lockheed. Order book ₹3000 Cr. TP ₹466 (+54%) Download... DCX Systems has the ability to become a key […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!